David Zelmanovic
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Iron Metabolism and Disorders
- Erythropoietin and Anemia Treatment
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Platelet Disorders and Treatments 5
- Iron Metabolism and Disorders 2
- Oncology 5
- Inflammatory Biomarkers in Disease Prognosis 5
- Co-authors
- David Okrongly (4 shared papers)Emma Chapman (3 shared papers)Adrian C. Newland (3 shared papers)Lee Webb (3 shared papers)Jyoti Chattopadhyay (1 shared paper)M. G. Macey (2 shared papers)E Carty (2 shared papers)Robert Mushnick (1 shared paper)
- Journals
- American Journal of Clinical Pathology (3 papers)Cytometry (2 papers)Clinical Chemistry (1 paper)Thrombosis and Haemostasis (1 paper)American Journal of Kidney Diseases (1 paper)
- Partner nations
- United StatesUnited KingdomBulgaria
In The Last Decade
David Zelmanovic
12 papers receiving 685 citations
Peers
Comparison fields: 5 of 80
- Hematology 320
- Internal Medicine 56
- Equine 21
- Genetics 112
- Oncology 150
Countries citing papers authored by David Zelmanovic
This map shows the geographic impact of David Zelmanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Zelmanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Zelmanovic more than expected).
Fields of papers citing papers by David Zelmanovic
This network shows the impact of papers produced by David Zelmanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Zelmanovic. The network helps show where David Zelmanovic may publish in the future.
Co-authors
The 25 scholars most cited alongside David Zelmanovic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 125 | |
| 2 | 1997 | 123 | |
| 3 | 1999 | 73 | |
| 4 | 1999 | 72 | |
| 5 | 1998 | 70 | |
| 6 | 2000 | 66 | |
| 7 | 1997 | 63 | |
| 8 | 2006 | 46 | |
| 9 | 2003 | 41 | |
| 10 | 2014 | 15 | |
| 11 | 2001 | 13 | |
| 12 | 2008 | 9 |
About David Zelmanovic
David Zelmanovic is a scholar working on Hematology, Oncology, Pulmonary and Respiratory Medicine, Physiology and Genetics, having authored 12 papers that have together received 716 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (5 papers), Platelet Disorders and Treatments (5 papers), Blood properties and coagulation (3 papers), Hemoglobinopathies and Related Disorders (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Iron Metabolism and Disorders (2 papers), Erythrocyte Function and Pathophysiology (2 papers) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Hematology (320 citations), Internal Medicine (56 citations), Equine (21 citations), Genetics (112 citations) and Oncology (150 citations). David Zelmanovic has collaborated with scholars based in United States, United Kingdom and Bulgaria. Frequent co-authors include David Okrongly, Emma Chapman, Adrian C. Newland, Lee Webb, Jyoti Chattopadhyay, M. G. Macey, E Carty, Robert Mushnick, Rajanna Sreedhara and Martin Sorette. Their work appears in journals such as American Journal of Clinical Pathology, Cytometry, Clinical Chemistry, Thrombosis and Haemostasis and American Journal of Kidney Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.